Key result
F18DG SPECT imaging identified viable myocardium in 58% of patients with ischemic left ventricular dysfunction, leading to revascularization in 29 patients with an 86% 30-day survival rate.
Why the study?
Does F18DG SPECT imaging for myocardial viability assessment influence clinical decisions in patients with ischemic left ventricular dysfunction?
Population
59 patients with documented coronary artery disease and depressed left ventricular function referred for…
Design
Cohort
Follow-up
30-day
Authors
Loading...
May guide revascularization decisions in ischemic LV dysfunction; leaves open outcome benefits versus standard care in RCTs.
Observational (n=59)
No
Does F18DG SPECT imaging for myocardial viability assessment influence clinical decisions in patients with ischemic left ventricular dysfunction?
Assessment of myocardial viability with F18DG SPECT imaging led to a clinical decision for revascularization in approximately half of patients with severe coronary disease and left ventricular dysfunction.
Calhoun et al. (1996) conducted an observational in Chronic ischemic heart failure (n=59). F18DG SPECT imaging for myocardial viability assessment was evaluated on Clinical decisions (revascularization vs medical therapy/transplantation) and 30-day mortality. F18DG SPECT imaging identified viable myocardium in 58% of patients with ischemic left ventricular dysfunction, leading to revascularization in 29 patients with an 86% 30-day survival rate.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: